September 2026
The next-gen delivery systems for genetic drug market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries
September 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.17 billion in 2026 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
September 2026
The pulmonary drug delivery systems market size reached USD 61.03 billion in 2026, with leading pulmonary drug delivery systems market companies including Philips Respironics, GlaxoSmithKline PLC, BoehringerIngelheim GmbH.
September 2026
The global transdermal drug delivery systems market size was evaluated at USD 87.46 billion in 2026 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
September 2026
The advanced drug delivery market size is calculated at USD 103.84 billion in 2026 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The global inhaled nitric oxide delivery systems market size is estimated to hit around USD 562.47 million by 2034 from USD 394.31 million in 2026, at a CAGR of 4.54%.
September 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 864.96 million in 2026, with a CAGR of 9.00%.
September 2026
The drug delivery devices market size reached USD 321.05 billion in 2026, with leading drug delivery devices market companies including Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd.
September 2026
The global nasal drug delivery technology market size is expected to surge around USD 179.41 billion by 2035 from USD 95.49 billion in 2026, growing at a CAGR of 7.28%.
September 2026
The exosome drug delivery services market size was USD 5.70 billion in 2026, with leading exosome drug delivery services market players including CD Bioarticles, Danaher, Fujifilm, Illumina.
September 2026
The global liposome drug delivery market size reached USDÂ 6.63 billion in 2026 and is projected to surpass around USD 13.12 billion by 2034, with a CAGR of 8.91%.
September 2026
The global insulin drugs and delivery devices market size is evaluated at USD 27.47 billion in 2026 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The implantable drug delivery devices market size is valued at USD 13.98 billion in 2026 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
September 2026
The global subcutaneous drug delivery devices market size was valued at USD 38.87 billion in 2026 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
September 2026
The global topical drug delivery market size was valued at USD 148.81 billion in 2026 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
September 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.17 trillion in 2026 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
September 2026
The global anti-epileptic drugs for pediatrics market size is estimated to hit around USD 3.25 billion by 2035 increasing from USD 1.62 billion in 2026, with a CAGR of 8.04%.
September 2026
The global healthcare information systems market size is projected to hit around USD 1,956.49 billion by 2035 from USD 666.77 billion in 2026 with a CAGR of 12.77%.
September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The global intranasal drug delivery devices market size surpassed USD 2,043.63 million in 2026 and is projected to hit around USD 4,949.45 million by 2035, with a noteworthy CAGR of 10.33%.
September 2026
The genetic editing for ASCVD market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The global thermal management for advanced driver-assistance systems market size is estimated to hit around USD 2,018.17 million by 2034 from USD 358.74 million in 2026, with a CAGR of 24.10%.
September 2026
The non-clinical information systems market reached USD 19.69 billion in 2026, with key non-clinical information systems market companies including Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, Epic Systems Corporation.
September 2026
The drug discovery informatics market size stood at USD 5.35 billion in 2026, with major drug discovery informatics companies including collaborative drug discovery inc, eurofins discoverx products, jubilant biosys, selvita, novo informatics pvt ltd.
July 2026
The global nanotechnology drug delivery market size was valued at USD 105.95 billion in 2025 and is expected to hit around USD 222.96 billion by 2035, growing at a CAGR of 7.72%.
July 2026
The global AI-powered drug formulation market is growing as pharmaceutical companies leverage AI to optimize drug design, delivery, and efficacy.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com